Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OREX

Orexigen Therapeutics (OREX) Stock Price, News & Analysis

Orexigen Therapeutics logo

About Orexigen Therapeutics Stock (NASDAQ:OREX)

Advanced Chart

Key Stats

Today's Range
$0.22
$0.32
50-Day Range
$0.22
$0.22
52-Week Range
$0.17
$3.81
Volume
3.74 million shs
Average Volume
1.16 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OREX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orexigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

OREX Stock News Headlines

Orexigen Therapeutics Stock Price History
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
Xeno Biosciences Announces New CEO and Financing
Orexigen Tanks After-Hours on Obesity Data
See More Headlines

OREX Stock Analysis - Frequently Asked Questions

Orexigen Therapeutics, Inc. (NASDAQ:OREX) posted its quarterly earnings data on Monday, November, 13th. The biopharmaceutical company reported ($1.35) EPS for the quarter, topping the consensus estimate of ($2.13) by $0.78. The company's quarterly revenue was up 170.0% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Orexigen Therapeutics investors own include Lexicon Pharmaceuticals (LXRX), Arena Pharmaceuticals (ARNA), MannKind (MNKD), Novavax (NVAX), Bristol Myers Squibb (BMY), Rexahn Pharmaceuticals (REXN) and ImmunoGen (IMGN).

Company Calendar

Last Earnings
11/13/2017
Today
7/10/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:OREX
CIK
1382911
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:OREX) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners